BIDOLI, PAOLO
BIDOLI, PAOLO
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Antiemetic activity of metoclopramide versus alizapride during cancer chemotherapy
1985 Zambetti, M; Bajetta, E; Bidoli, P; Verusio, C
[Radiologic examination in assessing the response to chemoradiotherapy of esophageal spinocellular carcinoma]
1989 Cozzi, G; Pestalozza, A; Bellomi, M; Bidoli, P; Gariboldi, M; Severini, A
Prognosis after nonradical resections for small cell lung carcinoma (SCLC)
1989 Bedini, A; Cataldo, I; Bidoli, P; Valente, M; Tavecchio, L; Muscolino, G; Ravasi, G
Pilot study with adriamycin and ifosfamide in small cell lung cancer
1989 Bidoli, P; Spinazzé, S; Santoro, A; Bedini, A; Cataldo, I; Bonadonna, G
Surgical resection in the treatment of stages I-II of small cell lung carcinoma (SCLC)
1989 Cataldo, I; Bedini, A; Muscolino, G; Valente, M; Pastorino, U; Bidoli, P; Pilotti, S; Ravasi, G
Pilot study with cisplatin, ifosfamide, and etoposide in advanced non-small-cell lung carcinoma
1990 Bidoli, P; Spinazzè, S; Santoro, A; Casali, P; Bedini, A; Guzzon, A
Esophageal squamous cell carcinoma: MRI evaluation of mediastinum
1990 Petrillo, R; Balzarini, L; Bidoli, P; Ceglia, E; D'Ippolito, G; Tess, J; Musumeci, R
Effect of prolonged subcutaneous administration of interleukin-2 on the circadian rhythms of cortisol and beta-endorphin in advanced small cell lung cancer patients
1991 Spinazzé, S; Viviani, S; Bidoli, P; Rovelli, F; Palmer, P; Franks, C; Arienti, F; Rivoltini, L; Parmiani, G
Normalization of the light/dark rhythm of melatonin after prolonged subcutaneous administration of interleukin‐2 in advanced small cell lung cancer patients
1992 Viviani, S; Bidoli, P; Spinazzé, S; Rovelli, F; Lissoni, P
Chronic effects of subcutaneous interleukin-2 therapy on soluble interleukin-2 receptors in advanced small cell lung cancer
1993 Viviani, S; Salvini, P; Bidoli, P; Camerini, E; Spinazzé, S; Arienti, F; Rivoltini, L; Motta, V
Esophageal carcinoma: radiochemotherapy
1993 Bidoli, P; Salvini, P
Combined radiation and chemotherapy in esophageal cancer
1993 Zucali, R; Bidoli, P; Salvini, P; Santoro, A; Spinazzè, S; Bonadonna, G; Valente, M; Alloisio, M; Ravasi, G
Drugs ten years later: epirubicin
1993 Bonadonna, G; Gianni, L; Santoro, A; Bonfante, V; Bidoli, P; Casali, P; Demicheli, R; Valagussa, P
A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: Attempts to improve long-term outcome
1995 Santoro, A; Parra, H; Bidoli, P; Angelidou, M; Cataldo, I; Salvini, P; Valagussa, P; Milani, F; Ravasi, G; Bonadonna, G
Comparative in vitro sensitivity of human cholangiocarcinoma and colon adenocarcinoma cells to anticancer agents
1997 Villa, R; Gornati, D; Zaffaroni, N; Veneroni, S; Bidoli, P; Severini, A
Nutritional support in patients with cancer of the esophagus: impact on nutritional status, patient compliance to therapy, and survival
1998 Bozzetti, F; Cozzaglio, L; Gavazzi, C; Bidoli, P; Bonfanti, G; Montalto, F; Soto Parra, H; Valente, M; Zucali, R
Gemcitabine plus vinorelbine as first-line chemotherapy in advanced nonsmall cell lung carcinoma a phase II trial
2000 Bajetta, E; Chiara Stani, S; De Candis, D; Bidoli, P; Mariani, L; Zilembo, N; Pozzi, P; Procopio, G
Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis
2000 Sampietro, G; Tomasic, G; Collini, P; Biganzoli, E; Boracchi, P; Bidoli, P; Pilotti, S
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors
2000 Bajetta, E; Zilembo, N; Bichisao, E; Martinetti, A; Buzzoni, R; Pozzi, P; Bidoli, P; Ferrari, L; Celio, L
Malignant mesothelioma in subjects with Marfan's syndrome and Ehlers-Danlos syndrome: only an apparent association?
2000 Bisconti, M; Bisetti, A; Bidoli, P